Paper38010703
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer.
Böttger F and 12 others. Mol Oncol, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer. Papers, record 38010703. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38010703
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Humans | |
| Female | |
| Male | |
| Aged | |
| Middle Aged | |
| Proteomics | |
| HMGB1 Protein | |
| Platinum | |
| Cohort Studies |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 24444 | Associazione Italiana per la Ricerca sul Cancro (AIRC) | PubMed | ||
| 2014-6816 | KWF Kankerbestrijding | PubMed | ||
| 91116017 | The Netherlands Organization for Scientific Research | PubMed | ||
| VUmc-Cancer Center Amsterdam | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25152373 | SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell. | Cell Signal | 2014 | https://conductscience.org/library/papers/25152373 | PubMed |
| 2 | 30208165 | DNA repair pathways and cisplatin resistance: an intimate relationship. | Clinics (Sao Paulo) | 2018 | https://conductscience.org/library/papers/30208165 | PubMed |
| 3 | 36776323 | Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone. | Front Oncol | 2023 | https://conductscience.org/library/papers/36776323 | PubMed |
| 4 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 5 | 30710758 | Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction. | J Proteomics | 2019 | https://conductscience.org/library/papers/30710758 | PubMed |
| 6 | 26040768 | Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis. | Tumour Biol | 2015 | https://conductscience.org/library/papers/26040768 | PubMed |
| 7 | 29083409 | Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. | Nat Genet | 2017 | https://conductscience.org/library/papers/29083409 | PubMed |
| 8 | 27364315 | The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. | J Thorac Oncol | 2016 | https://conductscience.org/library/papers/27364315 | PubMed |
| 9 | 24996221 | HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma. | Mol Cancer | 2014 | https://conductscience.org/library/papers/24996221 | PubMed |
| 10 | 27893326 | Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET). | J Clin Oncol | 2017 | https://conductscience.org/library/papers/27893326 | PubMed |
| 11 | 29566065 | Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts. | PLoS One | 2018 | https://conductscience.org/library/papers/29566065 | PubMed |
| 12 | 21332310 | Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients. | Pharmacogenomics | 2011 | https://conductscience.org/library/papers/21332310 | PubMed |
| 13 | 20007255 | On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. | Bioinformatics | 2010 | https://conductscience.org/library/papers/20007255 | PubMed |
| 14 | 18089836 | A new mechanism of 6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one dihydrochloride (TAS-103) action discovered by target screening with drug-immobilized affinity beads. | Mol Pharmacol | 2008 | https://conductscience.org/library/papers/18089836 | PubMed |
| 15 | 30171261 | mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer. | Oncogene | 2019 | https://conductscience.org/library/papers/30171261 | PubMed |
| 16 | 31524278 | FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression. | Oncol Rep | 2019 | https://conductscience.org/library/papers/31524278 | PubMed |
| 17 | 34645978 | A highly annotated database of genes associated with platinum resistance in cancer. | Oncogene | 2021 | https://conductscience.org/library/papers/34645978 | PubMed |
| 18 | 20066897 | Combined effect of rapamycin and cisplatin on survival of Hep-2 cells in vitro. | Oncol Res | 2009 | https://conductscience.org/library/papers/20066897 | PubMed |
| 19 | 29768183 | NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells. | Int J Biochem Cell Biol | 2018 | https://conductscience.org/library/papers/29768183 | PubMed |
| 20 | 36108662 | Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/36108662 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41293424 | Clinical application and drug resistance mechanism of gemcitabine. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/41293424 | PubMed |
| 40804938 | HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40804938 | PubMed |
| 40702552 | Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40702552 | PubMed |
| 40515965 | Canthaxanthin downregulates EGFR in NSCLC: network pharmacology, molecular docking, dynamics simulations, ADMET, and in-vitro analysis. | Mol Divers | 2026 | https://conductscience.org/library/papers/40515965 | PubMed |
| 39092034 | Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer. | Pak J Med Sci | 2024 | https://conductscience.org/library/papers/39092034 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38010703
GET https://conductscience.org/api/papers/v1/38010703/references?page=2